Neuroleptic malignant syndrome in a patient with stable dose of olanzapine

Neuroleptic malignant syndrome (NMS), a potentially fatal consequence due to typical neuroleptics, has been described so far. In the past few years, there has been increased use of atypical antipsychotic drugs. Cases of NMS related to atypical neuroleptics, such as olanzapine, are less common in spi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahoo, Manoj Kumar, Kamath, Sangita, Sharan, Abhijeet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629885/
https://www.ncbi.nlm.nih.gov/pubmed/29026773
http://dx.doi.org/10.4103/2249-4863.214969

Ejemplares similares

Ejemplares similares